Question 1
Regular
When monitoring a patient who is taking a cholinergic drug, the nurse will watch for which cardiovascular effect?
Correct!
Incorrect
The correct answer is: A
Rationale
Bradycardia. The cholinergic drugs stimulate the parasympathetic nervous system, which typically results in a decrease in heart rate. Monitoring for bradycardia is essential to ensure patient safety and appropriate drug response.
B: Tachycardia. Cholinergic drugs generally do not induce increased heart rates; instead, they promote a slower heart rate due to their action on the heart's pacemaker.
C: Vasoconstriction. Cholinergic drugs primarily cause vasodilation through the stimulation of the parasympathetic system, which counteracts vasoconstriction and does not lead to increased vascular resistance.
D: Palpitations. While palpitations can occur in various conditions, cholinergic drugs typically do not cause this sensation, as they promote a steadier heart rate rather than irregular rhythms.
Correct Answer: A
Rationale: Bradycardia. The cholinergic drugs stimulate the parasympathetic nervous system, which typically results in a decrease in heart rate. Monitoring for bradycardia is essential to ensure patient safety and appropriate drug response.
B: Tachycardia. Cholinergic drugs generally do not induce increased heart rates; instead, they promote a slower heart rate due to their action on the heart's pacemaker.
C: Vasoconstriction. Cholinergic drugs primarily cause vasodilation through the stimulation of the parasympathetic system, which counteracts vasoconstriction and does not lead to increased vascular resistance.
D: Palpitations. While palpitations can occur in various conditions, cholinergic drugs typically do not cause this sensation, as they promote a steadier heart rate rather than irregular rhythms.
Question 2
Regular
The nurse notes in a patient's medication history that the patient is taking pilocarpine. Based on this finding, the nurse interprets that the patient has which disorder?
Correct!
Incorrect
The correct answer is: B
Rationale
Pilocarpine indicates that the patient has glaucoma. This medication is commonly prescribed to decrease intraocular pressure in glaucoma patients, demonstrating its therapeutic role in managing this specific eye disorder.
A: Anticholinergic poisoning This condition typically involves symptoms resulting from excessive anticholinergic effects, contrasting with pilocarpine’s cholinergic properties aimed at increasing fluid secretion rather than causing toxicity.
C: Bladder atony Pilocarpine is not utilized to treat bladder atony; instead, it primarily addresses ocular conditions, making this association inappropriate in the context of the patient's medication history.
D: Myasthenia gravis While pilocarpine may influence saliva production, it does not directly treat myasthenia gravis, a neuromuscular disorder that requires different therapeutic interventions focused on muscle strength enhancement.
Correct Answer: B
Rationale: Pilocarpine indicates that the patient has glaucoma. This medication is commonly prescribed to decrease intraocular pressure in glaucoma patients, demonstrating its therapeutic role in managing this specific eye disorder.
A: Anticholinergic poisoning This condition typically involves symptoms resulting from excessive anticholinergic effects, contrasting with pilocarpine’s cholinergic properties aimed at increasing fluid secretion rather than causing toxicity.
C: Bladder atony Pilocarpine is not utilized to treat bladder atony; instead, it primarily addresses ocular conditions, making this association inappropriate in the context of the patient's medication history.
D: Myasthenia gravis While pilocarpine may influence saliva production, it does not directly treat myasthenia gravis, a neuromuscular disorder that requires different therapeutic interventions focused on muscle strength enhancement.
Question 3
Regular
A patient has had an overdose of an intravenous cholinergic drug. The nurse expects to administer which drug as an antidote?
Correct!
Incorrect
The correct answer is: D
Rationale
Atropine sulfate. This antidote counteracts the effects of cholinergic overdose by blocking acetylcholine receptors, which alleviates symptoms such as bradycardia and excessive salivation, restoring normal physiological function.
A: Atenolol. This beta-blocker primarily manages hypertension and arrhythmias, lacking the necessary action to reverse cholinergic toxicity and failing to address the overdose symptoms effectively.
B: Bethanechol. As a cholinergic agonist, it stimulates acetylcholine receptors, exacerbating the toxicity instead of mitigating it, thus worsening the patient's condition rather than providing any relief.
C: Dobutamine. This medication is a sympathomimetic agent used to treat heart failure, which does not interact with cholinergic pathways and therefore cannot counteract the effects of overdose from cholinergic drugs.
Correct Answer: D
Rationale: Atropine sulfate. This antidote counteracts the effects of cholinergic overdose by blocking acetylcholine receptors, which alleviates symptoms such as bradycardia and excessive salivation, restoring normal physiological function.
A: Atenolol. This beta-blocker primarily manages hypertension and arrhythmias, lacking the necessary action to reverse cholinergic toxicity and failing to address the overdose symptoms effectively.
B: Bethanechol. As a cholinergic agonist, it stimulates acetylcholine receptors, exacerbating the toxicity instead of mitigating it, thus worsening the patient's condition rather than providing any relief.
C: Dobutamine. This medication is a sympathomimetic agent used to treat heart failure, which does not interact with cholinergic pathways and therefore cannot counteract the effects of overdose from cholinergic drugs.
Question 4
Regular
A patient who has had abdominal surgery has been discharged on a cholinergic drug to assist in increasing gastrointestinal peristalsis. The nurse will teach this patient to look for which therapeutic effect?
Correct!
Incorrect
The correct answer is: C
Rationale
C: Passage of flatus. This therapeutic effect indicates that the cholinergic medication is successfully stimulating bowel activity, promoting gastrointestinal motility, and facilitating the expulsion of gas, which is crucial for recovery post-surgery.
A: Decreased pulse rate. While cholinergic drugs can affect heart rate, the primary focus after abdominal surgery is gastrointestinal function, making this effect less relevant in this context.
B: Abdominal cramping. Although cramping may occur with increased peristalsis, it is not a desired therapeutic outcome and could indicate discomfort or complications rather than successful medication effects.
D: Decreased urge to void. This option pertains to urinary function, which is unrelated to gastrointestinal peristalsis, making it irrelevant when assessing the therapeutic objectives of cholinergic drugs in this scenario.
Correct Answer: C
Rationale: C: Passage of flatus. This therapeutic effect indicates that the cholinergic medication is successfully stimulating bowel activity, promoting gastrointestinal motility, and facilitating the expulsion of gas, which is crucial for recovery post-surgery.
A: Decreased pulse rate. While cholinergic drugs can affect heart rate, the primary focus after abdominal surgery is gastrointestinal function, making this effect less relevant in this context.
B: Abdominal cramping. Although cramping may occur with increased peristalsis, it is not a desired therapeutic outcome and could indicate discomfort or complications rather than successful medication effects.
D: Decreased urge to void. This option pertains to urinary function, which is unrelated to gastrointestinal peristalsis, making it irrelevant when assessing the therapeutic objectives of cholinergic drugs in this scenario.
Question 5
Regular
A cholinergic drug is prescribed for a patient with a new diagnosis of myasthenia gravis, and the nurse provides instructions to the patient about the medication. What is important to include in the teaching?
Correct!
Incorrect
The correct answer is: C
Rationale
Take the medication 30 minutes before eating to improve swallowing and chewing. This timing enhances the drug's effectiveness, allowing for better muscle strength and coordination during meals, which is crucial for patients with myasthenia gravis.
A: Give daytime doses close together for maximal therapeutic effect. Spacing doses too closely can lead to an increase in side effects without necessarily improving therapeutic outcomes, which could be detrimental.
B: Take the medication with meals to avoid gastrointestinal distress. Consuming the medication with meals may diminish its absorption and effectiveness, undermining the treatment's potential benefits in managing symptoms.
D: Take the medication only if difficulty swallowing occurs during a meal. Waiting until swallowing issues arise compromises treatment effectiveness, as the medication needs to be taken proactively to prevent such difficulties.
Correct Answer: C
Rationale: Take the medication 30 minutes before eating to improve swallowing and chewing. This timing enhances the drug's effectiveness, allowing for better muscle strength and coordination during meals, which is crucial for patients with myasthenia gravis.
A: Give daytime doses close together for maximal therapeutic effect. Spacing doses too closely can lead to an increase in side effects without necessarily improving therapeutic outcomes, which could be detrimental.
B: Take the medication with meals to avoid gastrointestinal distress. Consuming the medication with meals may diminish its absorption and effectiveness, undermining the treatment's potential benefits in managing symptoms.
D: Take the medication only if difficulty swallowing occurs during a meal. Waiting until swallowing issues arise compromises treatment effectiveness, as the medication needs to be taken proactively to prevent such difficulties.
Question 6
Regular
A factory worker has been admitted to the emergency department after an industrial accident involving organophosphate insecticides. The nurse will prepare to administer which drug?
Correct!
Incorrect
The correct answer is: C
Rationale
Physostigmine is the drug the nurse will prepare to administer. This anticholinesterase inhibitor is effective in reversing the effects of organophosphate poisoning by increasing acetylcholine levels at synapses, thereby alleviating symptoms of toxicity.
A: Pilocarpine Stimulates muscarinic receptors to promote secretions and reduce intraocular pressure, but it does not counteract the toxic effects of organophosphate poisoning effectively.
B: Bethanechol Primarily acts on bladder and gastrointestinal motility but lacks the capacity to reverse the neurological impairment caused by organophosphate exposure.
D: Tacrine Functions as a cholinesterase inhibitor for Alzheimer's treatment, but its clinical application does not address the acute toxicity associated with organophosphate insecticide exposure.
Correct Answer: C
Rationale: Physostigmine is the drug the nurse will prepare to administer. This anticholinesterase inhibitor is effective in reversing the effects of organophosphate poisoning by increasing acetylcholine levels at synapses, thereby alleviating symptoms of toxicity.
A: Pilocarpine Stimulates muscarinic receptors to promote secretions and reduce intraocular pressure, but it does not counteract the toxic effects of organophosphate poisoning effectively.
B: Bethanechol Primarily acts on bladder and gastrointestinal motility but lacks the capacity to reverse the neurological impairment caused by organophosphate exposure.
D: Tacrine Functions as a cholinesterase inhibitor for Alzheimer's treatment, but its clinical application does not address the acute toxicity associated with organophosphate insecticide exposure.
Question 7
Regular
The nurse is providing teaching regarding drug therapy to the husband of a woman with Alzheimer's disease. She was diagnosed 3 months ago, has mild memory loss, and will be receiving donepezil. What is the drug's expected action?
Correct!
Incorrect
The correct answer is: D
Rationale
Donepezil may help to improve the mood and decrease confusion. This drug is an acetylcholinesterase inhibitor that enhances neurotransmitter levels, thus aiding cognitive function and alleviating symptoms associated with Alzheimer's disease, such as mood disturbances and confusion.
A: Prevents memory loss in later stages. Donepezil does not halt or prevent memory loss; it only aims to manage symptoms in the early and moderate stages of the disease.
B: Reverses the course of Alzheimer's disease. There is currently no therapy available that can reverse Alzheimer's disease; donepezil focuses solely on symptom management rather than altering the disease's progression.
C: Provides sedation to prevent agitation and restlessness. Sedation is not a therapeutic action of donepezil; its primary purpose is to enhance cognitive function rather than induce sleepiness or calmness in patients.
Correct Answer: D
Rationale: Donepezil may help to improve the mood and decrease confusion. This drug is an acetylcholinesterase inhibitor that enhances neurotransmitter levels, thus aiding cognitive function and alleviating symptoms associated with Alzheimer's disease, such as mood disturbances and confusion.
A: Prevents memory loss in later stages. Donepezil does not halt or prevent memory loss; it only aims to manage symptoms in the early and moderate stages of the disease.
B: Reverses the course of Alzheimer's disease. There is currently no therapy available that can reverse Alzheimer's disease; donepezil focuses solely on symptom management rather than altering the disease's progression.
C: Provides sedation to prevent agitation and restlessness. Sedation is not a therapeutic action of donepezil; its primary purpose is to enhance cognitive function rather than induce sleepiness or calmness in patients.
Question 8
Regular
A patient has been taking donepezil for 2 weeks as part of the treatment for early stages of Alzheimer's disease. Her daughter calls the prescriber's office and is upset because -Mother has not improved one bit! Which response by the nurse is appropriate?
Correct!
Incorrect
The correct answer is: C
Rationale
It may take up to 6 weeks to see an improvement.
This response accurately addresses the daughter's concerns by setting realistic expectations regarding the timeline for donepezil's efficacy in treating Alzheimer's. The nurse's reassurance helps mitigate anxiety while highlighting the importance of patience in the treatment process, as cognitive enhancements often manifest gradually over several weeks.
A: Increase the dosage to twice daily. Adjusting the dosage prematurely could lead to unnecessary side effects and does not account for the typical time frame needed for the medication to show effects.
B: It takes time for the cure to take effect. Donepezil is not a cure for Alzheimer's but a treatment to help manage symptoms; thus, this statement misrepresents the medication's purpose.
D: Take the medication on an empty stomach for improved absorption. While absorption is relevant, this suggestion does not directly address the timeline for observing any benefits from the medication.
Correct Answer: C
Rationale: It may take up to 6 weeks to see an improvement.
This response accurately addresses the daughter's concerns by setting realistic expectations regarding the timeline for donepezil's efficacy in treating Alzheimer's. The nurse's reassurance helps mitigate anxiety while highlighting the importance of patience in the treatment process, as cognitive enhancements often manifest gradually over several weeks.
A: Increase the dosage to twice daily. Adjusting the dosage prematurely could lead to unnecessary side effects and does not account for the typical time frame needed for the medication to show effects.
B: It takes time for the cure to take effect. Donepezil is not a cure for Alzheimer's but a treatment to help manage symptoms; thus, this statement misrepresents the medication's purpose.
D: Take the medication on an empty stomach for improved absorption. While absorption is relevant, this suggestion does not directly address the timeline for observing any benefits from the medication.
Question 9
Regular
A patient who has been diagnosed with Sj?┬Âgren's syndrome will be given cevimeline for the treatment of xerostomia. The nurse will monitor for what therapeutic effect?
Correct!
Incorrect
The correct answer is: B
Rationale
B: Stimulation of salivation. Cevimeline acts as a muscarinic agonist, promoting the secretion of saliva in patients with xerostomia associated with Sjögren's syndrome, thereby alleviating dry mouth symptoms effectively.
A: Reduction of salivation. This choice contradicts the intended purpose of cevimeline, which specifically aims to enhance salivary production rather than diminish it in patients suffering from dry mouth.
C: Reduction of gastrointestinal peristalsis. Cevimeline primarily targets salivary glands and does not predominantly influence gastrointestinal motility, making this option unrelated to the drug's therapeutic effects in xerostomia.
D: Improvement of fine-motor control. There is no direct relationship between cevimeline's mechanism of action and fine-motor skills, as the medication focuses solely on stimulating salivary gland function.
Correct Answer: B
Rationale: B: Stimulation of salivation. Cevimeline acts as a muscarinic agonist, promoting the secretion of saliva in patients with xerostomia associated with Sjögren's syndrome, thereby alleviating dry mouth symptoms effectively.
A: Reduction of salivation. This choice contradicts the intended purpose of cevimeline, which specifically aims to enhance salivary production rather than diminish it in patients suffering from dry mouth.
C: Reduction of gastrointestinal peristalsis. Cevimeline primarily targets salivary glands and does not predominantly influence gastrointestinal motility, making this option unrelated to the drug's therapeutic effects in xerostomia.
D: Improvement of fine-motor control. There is no direct relationship between cevimeline's mechanism of action and fine-motor skills, as the medication focuses solely on stimulating salivary gland function.
Question 10
Regular
The nurse is reviewing the mechanism of action of cholinergic drugs. The desired effects of cholinergic drugs come from the stimulation of which receptors?
Correct!
Incorrect
The correct answer is: A
Rationale
Muscarinic receptors. Cholinergic drugs primarily exert their desired effects through the stimulation of muscarinic receptors, which are responsible for various parasympathetic responses, including decreased heart rate and increased glandular secretion, contributing significantly to therapeutic outcomes.
B: Nicotinic Stimulation of nicotinic receptors primarily affects skeletal muscle and autonomic ganglia, leading to different physiological responses that do not align with the specific desired effects of cholinergic drugs.
C: Cholinergic The term cholinergic encompasses both muscarinic and nicotinic receptors. However, it does not specify the particular receptor type that mediates the desired effects of cholinergic drugs.
D: Ganglionic Ganglionic receptors are involved in autonomic nervous system transmission but do not directly mediate the specific responses targeted by cholinergic drugs, which focus on muscarinic receptor effects.
Correct Answer: A
Rationale: Muscarinic receptors. Cholinergic drugs primarily exert their desired effects through the stimulation of muscarinic receptors, which are responsible for various parasympathetic responses, including decreased heart rate and increased glandular secretion, contributing significantly to therapeutic outcomes.
B: Nicotinic Stimulation of nicotinic receptors primarily affects skeletal muscle and autonomic ganglia, leading to different physiological responses that do not align with the specific desired effects of cholinergic drugs.
C: Cholinergic The term cholinergic encompasses both muscarinic and nicotinic receptors. However, it does not specify the particular receptor type that mediates the desired effects of cholinergic drugs.
D: Ganglionic Ganglionic receptors are involved in autonomic nervous system transmission but do not directly mediate the specific responses targeted by cholinergic drugs, which focus on muscarinic receptor effects.
Question 11
Regular
A patient calls the clinic to speak to the nurse about taking an herbal product that contains ginkgo (Ginkgo biloba) to -help my memory. He states that he has read much information about the herbal product. Which statement by the patient indicates a need for further education?
Correct!
Incorrect
The correct answer is: C
Rationale
Taking aspirin or ibuprofen with ginkgo can increase the risk of bleeding, which indicates the patient lacks understanding of potential drug interactions and safety precautions necessary when using herbal supplements.
A: I know the FDA has not approved this herbal product, but I'd like to try it to see if it helps my memory. Acknowledging FDA status shows awareness of regulatory oversight regarding herbal products.
B: I need to watch for possible side effects, such as headaches, or stomach or intestinal upset. This statement reflects a responsible approach to monitoring adverse effects linked to herbal products, demonstrating appropriate patient awareness.
D: Ginkgo may cause increased bleeding, so I'll have to be careful when doing yard work. Recognizing the bleeding risk associated with ginkgo shows the patient understands necessary precautions to take while engaging in activities that may lead to injury.
Correct Answer: C
Rationale: Taking aspirin or ibuprofen with ginkgo can increase the risk of bleeding, which indicates the patient lacks understanding of potential drug interactions and safety precautions necessary when using herbal supplements.
A: I know the FDA has not approved this herbal product, but I'd like to try it to see if it helps my memory. Acknowledging FDA status shows awareness of regulatory oversight regarding herbal products.
B: I need to watch for possible side effects, such as headaches, or stomach or intestinal upset. This statement reflects a responsible approach to monitoring adverse effects linked to herbal products, demonstrating appropriate patient awareness.
D: Ginkgo may cause increased bleeding, so I'll have to be careful when doing yard work. Recognizing the bleeding risk associated with ginkgo shows the patient understands necessary precautions to take while engaging in activities that may lead to injury.
Question 12
Regular
A patient is receiving a dose of edrophonium. The nurse recognizes that this drug is given to determine the diagnosis of which disease?
Correct!
Incorrect
The correct answer is: C
Rationale
Myasthenia gravis is the disease for which edrophonium is administered to confirm diagnosis. This short-acting acetylcholinesterase inhibitor helps enhance communication between nerves and muscles, revealing characteristic muscle weakness associated with the condition.
A: Parkinson's disease This condition involves dopamine deficiency, not cholinergic dysfunction, making edrophonium ineffective for diagnosis or symptom assessment.
B: Multiple sclerosis This autoimmune disorder affects the central nervous system but does not respond to edrophonium, as it primarily involves demyelination rather than neuromuscular transmission issues.
D: Alzheimer's disease While Alzheimer's involves cholinergic deficits, edrophonium is not utilized for its diagnosis, focusing instead on cognitive decline rather than muscle strength assessment.
Correct Answer: C
Rationale: Myasthenia gravis is the disease for which edrophonium is administered to confirm diagnosis. This short-acting acetylcholinesterase inhibitor helps enhance communication between nerves and muscles, revealing characteristic muscle weakness associated with the condition.
A: Parkinson's disease This condition involves dopamine deficiency, not cholinergic dysfunction, making edrophonium ineffective for diagnosis or symptom assessment.
B: Multiple sclerosis This autoimmune disorder affects the central nervous system but does not respond to edrophonium, as it primarily involves demyelination rather than neuromuscular transmission issues.
D: Alzheimer's disease While Alzheimer's involves cholinergic deficits, edrophonium is not utilized for its diagnosis, focusing instead on cognitive decline rather than muscle strength assessment.
Question 13
Multiple Choice
A cholinergic drug is prescribed for a patient. The nurse checks the patient's medical history, knowing that this drug is contraindicated in which disorders?
Correct!
Incorrect
The correct answer is: B,C,E,F
Rationale
A cholinergic drug is contraindicated in gastrointestinal obstruction, bradycardia, hypotension, and chronic obstructive pulmonary disease. These conditions can worsen with increased cholinergic activity, leading to significant complications and adverse effects.
A: Bladder atony Bladder atony typically benefits from cholinergic drugs that stimulate bladder contractions, making this option suitable rather than contraindicated.
D: Alzheimer's disease Cholinergic medications are often used to manage symptoms in Alzheimer's disease, enhancing cognitive function rather than presenting contraindications.
Correct Answer: B,C,E,F
Rationale: A cholinergic drug is contraindicated in gastrointestinal obstruction, bradycardia, hypotension, and chronic obstructive pulmonary disease. These conditions can worsen with increased cholinergic activity, leading to significant complications and adverse effects.
A: Bladder atony Bladder atony typically benefits from cholinergic drugs that stimulate bladder contractions, making this option suitable rather than contraindicated.
D: Alzheimer's disease Cholinergic medications are often used to manage symptoms in Alzheimer's disease, enhancing cognitive function rather than presenting contraindications.
Question 14
Calculation(ans only)
A patient is receiving memantine 10 mg PO daily. The patient is unable to swallow pills, so an oral solution that contains 2 mg/mL is ordered. Identify how much will the patient receive per dose.
Correct!
Incorrect
The correct answer is: 5 ML
Rationale
5 mL
The patient requires 10 mg of memantine, and an oral solution concentration of 2 mg/mL means that to achieve this dosage, 5 mL must be administered, calculated by dividing 10 mg by 2 mg/mL.
A: 2 mL This volume provides only 4 mg of memantine, which is insufficient for the prescribed dosage of 10 mg.
B: 10 mL This volume exceeds the required 10 mg, delivering 20 mg instead, which can lead to overdosing.
C: 1 mL At this volume, only 2 mg of memantine is given, significantly less than the needed 10 mg dosage.
Correct Answer: 5 ML
Rationale: 5 mL
The patient requires 10 mg of memantine, and an oral solution concentration of 2 mg/mL means that to achieve this dosage, 5 mL must be administered, calculated by dividing 10 mg by 2 mg/mL.
A: 2 mL This volume provides only 4 mg of memantine, which is insufficient for the prescribed dosage of 10 mg.
B: 10 mL This volume exceeds the required 10 mg, delivering 20 mg instead, which can lead to overdosing.
C: 1 mL At this volume, only 2 mg of memantine is given, significantly less than the needed 10 mg dosage.